O6-Benzylguanine

From WikiMD's WELLNESSPEDIA

(Redirected from O6-benzylguanine)

O6-Benzylguanine is a synthetic derivative of guanine, a type of nucleotide, that is used as a chemotherapy agent. It is a substrate for the enzyme O6-alkylguanine-DNA alkyltransferase (AGT), which repairs DNA damage caused by alkylating agents. By binding to AGT, O6-benzylguanine inhibits the enzyme's activity, allowing the DNA damage caused by alkylating agents to persist and leading to cell death.

Mechanism of Action[edit]

O6-Benzylguanine acts as a potent inhibitor of the DNA repair enzyme O6-alkylguanine-DNA alkyltransferase (AGT). AGT is a protein that repairs DNA damage caused by alkylating agents, which are commonly used in chemotherapy. By binding to AGT, O6-benzylguanine prevents the enzyme from repairing DNA damage, leading to cell death.

Clinical Use[edit]

O6-Benzylguanine is used in combination with other chemotherapy drugs to treat certain types of cancer. It is typically administered intravenously.

Side Effects[edit]

Like all chemotherapy drugs, O6-Benzylguanine can cause side effects. These may include nausea, vomiting, diarrhea, and fatigue. More serious side effects can include low blood cell counts, which can lead to an increased risk of infection, bleeding, and anemia.

See Also[edit]

References[edit]


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.